Hemorrhagic Fever - 27 Studies Found

Recruiting : Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
: Ebola Virus Survivor
: 2016-02-24
: Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240
Completed : GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
: Persistent Ebola Virus
: 2016-06-28
:
  • Drug: GS-5734 Daily GS-5734 de
Active, not recruiting : Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
: Prevention of Ebola Infection
: 2015-07-17
:
  • Biological: V920 Consistency Lot A

Not yet recruiting : MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
:
  • Ebola Disease
  • Marburg Disease

: 2016-09-01
:
  • Biological: Ad26 Zaire Ebola Vaccine

Completed : Evaluating an Ebola and a Marburg Vaccine in Uganda
:
  • Ebola Virus Disease
  • Marburg Virus Disease

: 2009-10-16
:
  • Biological: Ebola vaccine 4 mg
Completed : Ebola and Marburg Virus Vaccines
:
  • Ebola Vaccines
  • Marburg Virus Disease
  • Drug: VRC-EBODNA023-00-VP
  • Drug: VRC-MARDNA
Completed : Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS
: Hemorrhagic Fever With Renal Syndrome
: 2025-09-05
: Based upon clinical classification of HFRS , the patients were classified into four types
<<< Previous